Quality of Life Impact of Nasal Airway Treatment With Aerin Medical Device

CompletedOBSERVATIONAL
Enrollment

39

Participants

Timeline

Start Date

October 30, 2017

Primary Completion Date

July 9, 2022

Study Completion Date

July 9, 2022

Conditions
Nasal Obstruction
Interventions
DEVICE

Vivaer Stylus

Previous nasal obstruction treatment with the Aerin Medical Vivaer Stylus

Trial Locations (8)

10941

ENT and Allergy Associates, LLP, Middletown

11042

ENT and Allergy Associates, LLP, New Hyde Park

11360

ENT and Allergy Associates, LLP, Bayside

27103

Piedmont Ear, Nose and Throat Associates, Winston-Salem

75070

Ear, Nose and Throat Associates of Texas, McKinney

80909

Colorado ENT and Allergy, Colorado Springs

93720

Central California Clinical Research, Fresno

07649

ENT and Allergy Associates, LLP, Oradell

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Aerin Medical

INDUSTRY

NCT03290300 - Quality of Life Impact of Nasal Airway Treatment With Aerin Medical Device | Biotech Hunter | Biotech Hunter